| Patent Number |
Title Of Patent |
Date Issued |
| 6110906 |
Androgen derivatives for use in the inhibition of sex steroid activity |
August 29, 2000 |
| Methods for treating sex steroid-dependent diseases by inhibiting sex steroid activity include administration of novel compounds which include an androgenic nucleus substituted at a ring carbon with at least one substituent specified herein. Such compounds may function by inhibiting |
| 6015806 |
Antiandrogens |
January 18, 2000 |
| Androgen nucleus derivatives having specified substituents at the 17.alpha. position are disclosed for use as antiandrogens for the treatment of androgen-dependent diseases. In some preferred embodiments, the compound ##STR1## is formulated together with pharmaceutically acceptable d |
| 5686437 |
Estrogen nucleus derivatives for use in the inhibition of sex steroid activity |
November 11, 1997 |
| Novel derivatives of estrogenic nuclei, contain a side-chain substitution of the formula --R.sup.1 [B--R.sup.2 --].sub.x L--G and may be used in pharmaceutical compositions as sex steroid activity inhibitors useful in the treatment of both androgen-related and estrogen-related diseases. |
| 5631249 |
Estrogen nucleus derivatives for use in the inhibition of sex steroid activity |
May 20, 1997 |
| Novel compounds for the inhibition of sex steroid activity for the treatment of both androgen-related and estrogen-related diseases include for example 15- and 16-halo substituted compounds such as: ##STR1## The compounds are characterized by an estrogenic nucleus substituted with |
| 5585405 |
Inhibitors of sex steroid biosynthesis and methods for their production and use |
December 17, 1996 |
| Certain steroidal and non-steroidal compounds have been found to inhibit androgen and estrogen formation. Such inhibition may aid in the reduction of the activity of these hormones and may be useful in the treatment of diseases where, for example, inhibition of androgen or estrogen activ |
| 5204337 |
Estrogen nucleus derivatives for use in inhibition of sex steroid activity |
April 20, 1993 |
| Novel compounds for the inhibition of sex steroid activity for the treatment of both androgen-related and estrogen-related diseases include for example 15- and 16-halo substituted compounds such as: ##STR1## The compounds are characterized by an estrogenic nucleus substituted with |
